Our Newsroom
This is the place to get the latest exciting news about Route 92 medical.
Real World Data Supports Results of Route 92 Medical’s SUMMIT MAX Clinical Trial
Company also announces new 500-patient SUMMIT RISE study at the Society of NeuroInterventional Surgery annual meeting SAN MATEO, Calif., July 14, 2025 (GLOBE NEWSWIRE) – Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced results from an independent, real-world study evaluating reperfusion outcomes […]
View More
Route 92 Medical Announces Completion of Enrollment in the SUMMIT MAX Clinical Trial
View More
Route 92 Medical Announces the 100th Patent for its Neurovascular Intervention Portfolio
View More
Route 92 Medical Raises Over $31 Million in Oversubscribed Series F Equity Financing to Accelerate its Commercialization into the Rapidly Growing Stroke Treatment Market
View More